Region braces for end of UI benefit bonus
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Teledyne stock climbs as Q2 earnings beat analyst estimates
Second-quarter sales for Thousand Oaks-based Teledyne Technologies dipped 5 percent to $743.3 million, and net income beat analyst estimates, sending the stock up 2.5 percent in early trading. Net income fell around 10 percent compared to the previous year’s second quarter to $93.7 million, or $2.48 per share, squarely beating analyst predictions of around $2 Read More →
Sierra Bancorp Q2 earnings down
Sierra Bancorp, a Porterville-based banking company with 11 branches in the Tri-Counties, announced July 20 that its quarterly earnings were slightly down compared to the same period in 2019, led by a lower consolidated net income and lower return on both average assets and average equity. The parent company of Bank of the Sierra declared Read More →
Amgen puts $421M into BeiGene
Thousand Oaks biotech giant Amgen has upped its investment in Chinese oncology research firm BeiGene by $421 million. Amgen’s new investment, announced July 13, will allow the company maintain its ownership interest in BeiGene at 20.3 percent following a direct offering by the Chinese firm. Amgen shares rose more than 1 percent following the news Read More →
Several tri-county companies got at least $5M in PPP funding
At least a dozen companies in the Tri-Counties received more than $5 million each in Paycheck Protection Program funding since the start of the COVID-19 pandemic, according to data released July 6 by the Trump administration. The companies’ names were listed because of the size of the loans they took out. All companies who took Read More →
Inogen shaking things up
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Judge upholds Amgen’s Enbrel patents
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
